ZA932440B - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
ZA932440B
ZA932440B ZA932440A ZA932440A ZA932440B ZA 932440 B ZA932440 B ZA 932440B ZA 932440 A ZA932440 A ZA 932440A ZA 932440 A ZA932440 A ZA 932440A ZA 932440 B ZA932440 B ZA 932440B
Authority
ZA
South Africa
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Application number
ZA932440A
Other languages
English (en)
Inventor
John E Macor
Martin James Wythes
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA932440B publication Critical patent/ZA932440B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA932440A 1992-04-07 1993-04-05 Indole derivatives ZA932440B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86473792A 1992-04-07 1992-04-07

Publications (1)

Publication Number Publication Date
ZA932440B true ZA932440B (en) 1994-10-05

Family

ID=25343950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932440A ZA932440B (en) 1992-04-07 1993-04-05 Indole derivatives

Country Status (26)

Country Link
US (7) US5747501A (fr)
EP (1) EP0635017A1 (fr)
JP (1) JP2644088B2 (fr)
KR (1) KR0179072B1 (fr)
CN (2) CN1050841C (fr)
AU (1) AU670579B2 (fr)
BR (1) BR9306201A (fr)
CA (1) CA2133413C (fr)
CZ (1) CZ281763B6 (fr)
EG (1) EG20226A (fr)
FI (1) FI931558A (fr)
HR (1) HRP930752A2 (fr)
HU (1) HUT64062A (fr)
IL (1) IL105206A (fr)
MX (1) MX9302011A (fr)
MY (1) MY108909A (fr)
NO (1) NO303388B1 (fr)
NZ (1) NZ251086A (fr)
PL (1) PL172405B1 (fr)
RU (1) RU2101283C1 (fr)
SK (1) SK280193B6 (fr)
TW (1) TW341565B (fr)
UA (1) UA27467C2 (fr)
WO (1) WO1993020073A1 (fr)
YU (1) YU48931B (fr)
ZA (1) ZA932440B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
CA2133413C (fr) * 1992-04-07 2001-04-10 John Eugene Macor Derives de l'indole comme antagonistes de 5-ht1
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
CA2169179C (fr) * 1993-08-31 2000-02-29 John E. Macor Derives du 5-arylindole
CA2190501A1 (fr) * 1994-05-19 1995-11-30 Jose Luis Castro Pineiro Derives piperazine, piperidine et tetrahydropyridine d'indol-3-ylalkyle utilises comme agonistes de 5-ht1d-alpha
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
CA2207201A1 (fr) * 1994-12-06 1996-06-13 Caroline Henry Derives de l'azetidine, de la pyrrolidine et de la piperidine utilises comme agonistes des recepteurs 5-ht1
TR199800157T1 (xx) * 1995-07-31 1998-06-22 Shionogi & Co.,Ltd. Fosfolipaz A2 inhibit�r� aktivitesi olan pirolidin t�revleri.
GB9519558D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
US6051593A (en) * 1997-06-20 2000-04-18 Sugen, Inc. 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
AU4850199A (en) * 1998-06-30 2000-01-17 Eli Lilly And Company Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
CA2339662A1 (fr) * 1998-08-07 2000-02-17 Takeda Chemical Industries, Ltd. Derives de benzothiepine, leur procede de preparation et leurs utilisations
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
CA2635010A1 (fr) * 2005-12-30 2007-07-19 Amjad Ali Inhibiteurs de cetp
WO2010043396A1 (fr) * 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Dérivés d’indole et de benzomorpholine en tant que modulateurs des récepteurs métabotropiques du glutamate
US20100217013A1 (en) * 2008-12-15 2010-08-26 Wenge Li Enantioselective process for the preparation of zolmitriptan
CA2891122C (fr) 2012-11-14 2021-07-20 The Johns Hopkins University Methodes et compositions pour le traitement de la schizophrenie
PL3447051T3 (pl) 2016-04-28 2022-03-14 Jiangsu Hengrui Medicine Co., Ltd. Sposób otrzymywania inhibitora kinazy tyrozynowej i jego pochodnej
CA3166940A1 (fr) * 2020-02-04 2021-08-12 Abdelmalik Slassi Derives de 3-pyrrolidine-indole en tant qu'agents psychedeliques serotoninergiques pour le traitement de troubles du snc

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
BE889931A (fr) * 1980-08-12 1982-02-11 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
US4689336A (en) * 1981-01-02 1987-08-25 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine 2,4-diones
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
FR2601008B1 (fr) * 1986-07-03 1990-03-30 Sanofi Sa Procede de synthese stereospecifique de derives de l'indole
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
IL98392A (en) * 1990-06-07 1996-01-19 Wellcome Found History of indole, their preparation and the pharmaceutical preparations containing them
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
BR9106978A (pt) * 1990-10-15 1993-09-28 Pfizer Derivados de indol
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (fr) * 1991-02-12 1995-11-21 Pfizer
KR0184911B1 (ko) 1991-11-25 1999-05-01 알렌 제이. 스피겔 인돌유도체
CA2083891A1 (fr) * 1991-12-03 1993-06-04 Angus Murray Macleod Composes heterocycliques, compositions et utilisation therapeutique
US5409941A (en) 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (fr) 1992-03-05 1996-10-11 Pfizer
CA2133413C (fr) * 1992-04-07 2001-04-10 John Eugene Macor Derives de l'indole comme antagonistes de 5-ht1
UA34452C2 (uk) 1992-04-10 2001-03-15 Пфайзер Інк. Похідні ациламіноіндолу, що проявляють серотонінову 5-нт1 агоністичну активність та похідні аміноіндолу як проміжні сполуки

Also Published As

Publication number Publication date
MX9302011A (es) 1994-03-31
CN1050841C (zh) 2000-03-29
RU94045897A (ru) 1996-09-10
KR950700906A (ko) 1995-02-20
NZ251086A (en) 1996-09-25
US6410739B1 (en) 2002-06-25
CN1082543A (zh) 1994-02-23
NO943762D0 (no) 1994-10-06
SK120694A3 (en) 1995-05-10
IL105206A (en) 1999-04-11
US6387937B1 (en) 2002-05-14
CN1083443C (zh) 2002-04-24
SK280193B6 (sk) 1999-09-10
EG20226A (en) 1997-12-31
HU9301003D0 (en) 1993-06-28
US6436957B1 (en) 2002-08-20
YU23893A (sh) 1996-10-09
RU2101283C1 (ru) 1998-01-10
MY108909A (en) 1996-11-30
FI931558A (fi) 1993-10-08
NO303388B1 (no) 1998-07-06
FI931558A0 (fi) 1993-04-06
UA27467C2 (uk) 2000-09-15
PL172405B1 (en) 1997-09-30
AU670579B2 (en) 1996-07-25
CZ246494A3 (en) 1995-06-14
US6465500B1 (en) 2002-10-15
CA2133413C (fr) 2001-04-10
YU48931B (sh) 2002-12-10
US5747501A (en) 1998-05-05
CN1225362A (zh) 1999-08-11
US6387941B1 (en) 2002-05-14
HUT64062A (en) 1993-11-29
CA2133413A1 (fr) 1993-10-14
TW341565B (en) 1998-10-01
JP2644088B2 (ja) 1997-08-25
KR0179072B1 (ko) 1999-03-20
WO1993020073A1 (fr) 1993-10-14
IL105206A0 (en) 1993-07-08
US6150388A (en) 2000-11-21
NO943762L (no) 1994-10-06
CZ281763B6 (cs) 1997-01-15
AU3789893A (en) 1993-11-08
EP0635017A1 (fr) 1995-01-25
JPH07504919A (ja) 1995-06-01
BR9306201A (pt) 1998-06-23
HRP930752A2 (en) 1994-10-31

Similar Documents

Publication Publication Date Title
GB2266091B (en) Indole derivatives
GB2251614B (en) Indole derivatives
ZA932440B (en) Indole derivatives
ZA942383B (en) New indole derivatives
IL105312A0 (en) Indoles
ZA941483B (en) Indole derivatives
GB9326332D0 (en) Indole derivatives
GB9319297D0 (en) Indole derivatives
AP9400685A0 (en) Indole derivatives
EP0512350A3 (en) Indole derivatives
AP9400633A0 (en) Indole derivatives
GB9116732D0 (en) Indole derivatives
GB9204024D0 (en) Indole derivatives
GB9302577D0 (en) Indole derivatives
IL121326A0 (en) Indole derivatives
GB9206809D0 (en) Indole derivatives
GB9206056D0 (en) Indole derivatives
GB9206810D0 (en) Indole derivatives
GB9206787D0 (en) Indole derivatives
GB9215961D0 (en) Indole derivatives
GB9206794D0 (en) Indole derivatives
GB9218595D0 (en) Indole derivatives
GB9307080D0 (en) Indole derivatives
GB9319299D0 (en) Indole derivatives
GB9309148D0 (en) Indole derivatives